Navigation Links
Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
Date:11/1/2011

br>-Global Brands net revenue increased 11 percent to $110.3 million in the third quarter 2011 as a result of increased sales of key promoted products, including RAPAFLO®, Gelnique®, Trelstar®,  Crinone®, and Generess™ Fe.  

Adjusted gross margin for the Global Brands segment decreased 2.6 percentage points in the third quarter to 77.5 percent as a result of product mix.

Shortly following the end of the quarter, Watson received approval for its 2 mg and 4 mg formulation of Androderm®. The new smaller size and lower-dose testosterone patch provides highly effective testosterone administration with a 20 percent reduction in the active ingredient from the original strength in a smaller patch size. Watson plans to launch the new Androderm® formulation in the fourth quarter.

Global Brands R&D investment decreased 13 percent to $18.8 million in the third quarter 2011 as a result lower contractual milestone payments when compared with the third quarter of 2010. The decrease was partially offset by increased biosimilar R&D investment and other costs.  Selling and marketing expenses increased 19 percent to $40.8 million as a result of increased field force and support costs, including expansion costs in Canada.

Distribution Segment InformationThree Months EndedNine Months EndedSeptember 30,September 30,(Unaudited; $ in millions)

2011201020112010Net revenue

$
8.8$
205.1$
524.8$
27.3Operating expenses:Cost of sales

140.1174.6438.1535.6Selling and marketing

18.317.356.453.3Segment contribution

$
.4$
3.2$
30.3$
38.4Segment margin

6.2%6.4%5.8%6.1%Gross profit

$
28.7$
30.5$
86.7$
91.7Gross margin

17.0%14.9%16.5%14.6%Distribution segment net revenue for the third quarter 2011 decreased 18 percent to $168.8 million due to fewer third-party product launches in the quarter.  Distribution revenue
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
2. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
3. Watson Confirms Daytrana(R) Patent Challenge
4. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
5. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
6. Watson Confirms EMBEDA(R) Patent Challenge
7. Watson Launches Generic FEMCON(R) Fe
8. Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings
9. Watson to Present at the Jefferies 2011 Global Healthcare Conference
10. Watson Confirms Amphastar Patent Lawsuit
11. Watson Pharmaceuticals Announces Approval of Amphastars Generic LOVENOX(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... China based on the number of directly ... General Meeting of Shareholders (the "AGM") on October 22, 2014 at ... meeting room of the Company at 6th Floor, Tower B, Xinnengyuan ... Guangdong Province 518054, People,s Republic of ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
(Date:9/19/2014)... N.C. , Sept. 19, 2014 A ... Best Practices, LLC with three issues he wanted the ... The use of external personnel (especially for secondary research) ... in the face of increased workload , Automation ... better knowledge management , How to implement and ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... world-leading developer and marketer of innovative medical technologies for ... Bradford (Brad) Barton as President, ConvaTec U.S.   ... the ConvaTec U.S. organization across the company,s three core ... and Critical Care.   Barton joined ConvaTec ...
... SPRING, Md., Nov. 9, 2010 The U.S. Food ... undergoing computed tomography (CT) brain perfusion scans were accidently ... properly used, the CT scanners did not malfunction. Instead, ... scanners resulted in these overdoses. However, the FDA has ...
Cached Medicine Technology:Bradford Barton Named President, ConvaTec U.S. 2FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3
(Date:9/22/2014)... ARBOR, Mich. A surprising new study pulls back ... in health care: differences in payment and income between ... who don,t. , Contrary to perception, the research ... to favor surgeons and other procedure-performing doctors. , The ... simple difference in pay per minute explains why doctors ...
(Date:9/22/2014)... Amy Norton HealthDay Reporter ... may fare better when newborn intensive care units (NICU) set ... infants, a new study finds. Researchers at one children,s ... and were less distressed when their NICU switched from the ... findings, published online Sept. 22 in the journal Pediatrics ...
(Date:9/22/2014)... patients undergoing breast cancer surgery require additional operations because ... in the initial operation. However, researchers at Brigham and ... developed that will help surgeons better distinguish cancerous breast ... repeat operations. , The study is ... the Proceedings of the National Academy of Sciences ...
(Date:9/22/2014)... scientists have found that an anticonvulsant drug may help ... Although dozens of antibiotics target what bacteria do, their ... bacteria are created, and they found there is a ... important as there is growing concern worldwide about how ... The World Health Organization has declared that antibiotic resistance ...
(Date:9/22/2014)... September 22, 2014 This Flash Report ... stakeholder management needs for the Prostate Cancer market. , ... on stakeholder strategies for any launching Prostate Cancer product:, ... differentiation within an increasingly crowded market , ... impact of identifying community-based thought leaders and stakeholders ...
Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:The fine line between breast cancer and normal tissues 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2
... protein previously thought not to exist in adult human lungs ... scientists have found, but it also has a major role ... cancers. The protein, called the calcium-sensing receptor, sits on ... known as squamous-cell carcinomas, according to new research. As ...
... new source of stem cells A team ... Institute for Biological Studies, La Jolla, has generated data in ... tissue in the smell-sensing region of the human nose (human ... cells to treat brain disorders in which nerve cells are ...
... couples is affected by wives, inability to fall asleep at ... that will be presented Monday, June 13, in Minneapolis, Minn., ... Professional Sleep Societies LLC (APSS). Results show ... predicted their reports of more negative and less positive marital ...
... studied controversial aspects of Medicare spending and quality ... from the nation,s largest health services research professional ... 2011 Article of the Year Award to Jeffrey ... for Outcomes Research at The Children,s Hospital of ...
... MONDAY, June 13 (HealthDay News) -- Breast-feeding appears to reduce ... especially when babies are exclusively breast-fed, a new study suggests. ... infants, and studies have shown breast-feeding aids babies, development and ... mothers. Now, there is more evidence that breast-feeding may reduce ...
... about the signs and symptoms of drug impairment among ... Houston State University (SHSU) June 14. The free, six-hour ... Sept. 1, 2011., The program, funded by the Texas ... including human resources personnel, owners and executive staff. The ...
Cached Medicine News:Health News:Scientists identify key component in lethal lung cancer complication 2Health News:Scientists identify key component in lethal lung cancer complication 3Health News:Scientists identify key component in lethal lung cancer complication 4Health News:JCI online early table of contents: June 13, 2011 2Health News:JCI online early table of contents: June 13, 2011 3Health News:JCI online early table of contents: June 13, 2011 4Health News:JCI online early table of contents: June 13, 2011 5Health News:JCI online early table of contents: June 13, 2011 6Health News:JCI online early table of contents: June 13, 2011 7Health News:JCI online early table of contents: June 13, 2011 8Health News:JCI online early table of contents: June 13, 2011 9Health News:JCI online early table of contents: June 13, 2011 10Health News:Study finds that wives' sleep problems have negative impact on marital interactions 2Health News:Hospital outcomes research named 'Article of the Year' 2Health News:Hospital outcomes research named 'Article of the Year' 3Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 2Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 3Health News:Drug recognition program available for Texas employers 2
Fixed smooth rod which slides on skin. Designated most popular model or size....
Grooved roller, on which knife oscillates....
Disposable. For use with the N4086....
30 mm button end blade. Flat handle....
Medicine Products: